NIH to Launch Human Safety Study of Ebola Vaccine Candidate

Trial is First in Series of Accelerated Safety Studies of Ebola Vaccines

Initial human testing of an investigational vaccine to prevent Ebola virus disease will begin next week by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

Read more View All News

This page was last updated on Friday, January 21, 2022